business

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

CNBC · May 12, 2026, 11:05 AM · Also reported by 3 other sources

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

Read full story on CNBC → More top stories

Also covered by

Yahoo Finance Hims & Hers stock sinks after quarterly loss, sales miss Investing.com Thyssenkrupp Nucera’s second-quarter net loss widens Investing.com AST SpaceMobile shares tumble 12% on wider-than-expected first quarter loss

Aggregated and edited by the Scoop newsroom. We surface news from CNBC alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Also covered by

More in business